39,226 Shares in CVS Health Corporation $CVS Bought by Te Ahumairangi Investment Management Ltd

Te Ahumairangi Investment Management Ltd bought a new stake in CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 39,226 shares of the pharmacy operator’s stock, valued at approximately $4,058,000.

Several other institutional investors have also made changes to their positions in CVS. Caitong International Asset Management Co. Ltd lifted its stake in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new stake in CVS Health in the fourth quarter worth $26,000. Kilter Group LLC bought a new position in CVS Health during the second quarter valued at about $27,000. Sankala Group LLC acquired a new stake in shares of CVS Health in the fourth quarter worth about $28,000. Finally, Global Trust Asset Management LLC boosted its stake in shares of CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 300 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CVS shares. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Mizuho boosted their price objective on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. HSBC reiterated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a research note on Monday, July 6th. Piper Sandler restated an “overweight” rating and set a $113.00 price target on shares of CVS Health in a report on Monday, June 1st. Finally, Bank of America lifted their price objective on CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Price Performance

Shares of CVS stock opened at $93.01 on Monday. The stock’s fifty day simple moving average is $102.02 and its 200 day simple moving average is $88.95. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The firm has a market cap of $118.96 billion, a price-to-earnings ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same period in the prior year, the company posted $1.81 earnings per share. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.